Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SEL1L | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | KIF1A | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
mRNA | RPA2 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
mRNA | C1QTNF7 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | RAD9A | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
mRNA | LIMA1 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
mRNA | SH2D5 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
mRNA | MCM7 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | ITGB1 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
mRNA | BICC1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |